The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules

Journal of Neurochemistry

Volumn 74, Issue 6, 2000, Pages 2583-2589

  Perez M ^a   Lim, F ^a   Arrasate, M ^a   Avila, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Frontotemporal dementia and parkinsonism linked to chromosome 17; Mutant tau; Nocodazole; Phosphorylation; Tau

Indexed keywords

CASEIN KINASE I; NOCODAZOLE; TUBULIN;

ARTICLE; CHROMOSOME 17; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; MICROTUBULE; NEUROLOGIC DISEASE; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 17; COS CELLS; DEMENTIA; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROTUBULES; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NEUROFIBRILLARY TANGLES; NOCODAZOLE; PARKINSON DISEASE; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; SERINE; TAU PROTEINS; TRANSFECTION; TUBULIN;

EID: 0342368837     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0742583.x     Document Type: Article

References (30)

1. Armas-Portela R., Parrales M., Albar J., Martínez-Alonso C., and Avila J. (1999) Distribution and characteristics of beta II tubulin-enriched microtubules in interphase cells. Exp. Cell Res. 248, 372-380.
2. Arrasate M., Perez M., Armas Portela R., and Avila J. (1999) Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett. 446, 199-202.
3. Biernat J. and Mandelkow E. M. (1999) The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol. Biol. Cell 10, 727-740.
4. Blom N., Gammeltoft S., and Brumak S. (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351-1362.
5. Correas I., Diaz Nido J., and Avila J. (1992) Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. J. Biol. Chem. 267, 15721-15728.
6. Dayanandan R., VanSlegtenhorst M., Mack T. G. A., Ko L., Yen S. H., Leroy K., Brion J. P., Anderton B. H., Hutton M., and Lovestone S. (1999) Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 446, 228-232.
7. Goedert M., Spillantini M. G., Jakes R., Rutherford D., and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
8. Goedert M., Jakes R., and Crowther R. A. (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450, 306-311.
9. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87, 5827-5831.
10. Hasegawa M., Smith M. J., and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
11. Hong M., Zhukareva V., Vogelsberg Ragaglia V., Wszolek Z., Reed L., Miller B. I., Geschwind D. H., Bird T. D., McKeel D., Goate A., Morris J. C., Wilhelmsen K. C., Schellenberg G. D., Trojanowski J. Q., and Lee V. M. Y. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917.
12. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., PickeringBrown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R. C., Stevens M., deGraaff E., Wauters E., vanBaren J., Hillebrand M., Joosse M., Kwon J. M., Nowotny P., Che L. K., Norton J., Morris J. C., Reed L. A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P. R., Hayward N., Kwok J. B. J., Schofield P. R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B. A., Hardy J., Goate A., van Swieten J., Mann D., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
13. Kanai Y., Chen J. G., and Hirokawa N. (1992) Microtubule bundling by tau proteins in vivo - analysis of functional domains. EMBO J. 11, 3953-3961.
14. Litersky J. M. and Johnson G. V. W. (1995) Phosphorylation of τ in situ: inhibition of calcium-dependent proteolysis. J. Neurochem. 65, 903-911.
15. Lu P. J., Wulf G., Zhou X. Z., Davies P., and Lu K. P. (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788.
16. Matsumura N., Yamazaki T., and Ihara Y. (1999) Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am. J. Pathol. 154, 1649-1656.
17. Montejo de Garcini E., Delaluna S., Dominguez J. E., and Avila J. (1994) Overexpression of tau protein in COS-1 cells results in the stabilization of centrosome-independent microtubules and extension of cytoplasmic processes. Mol. Cell. Biochem. 130, 187-196.
18. Muñoz Montano J. R., Moreno F. J., Avila J., and Diaz Nido J. (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411, 183-188.
19. Nacharaju P., Lewis J., Easson C., Yen S., Hackett J., Hutton M., and Yen S. H. (1999) Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195-199.
20. Novak M., Jakes R., Edwards P. C., Milstein C., and Wischik C. M. (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc. Natl. Acad. Sci. USA 88, 5837-5841.
21. Otvos L., Feiner L., Lang E., Szendrei G. I., Goedert M., and Lee V. M. Y. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39, 669-673.
22. Pérez M., Valpuesta J. M., Medina M., Montejo de Garcini E., and Avila J. (1996) Polymerization of τ into filaments in the presence of heparin: the minimal sequence required for τ-τ interaction. J. Neurochem. 67, 1183-1190.
23. Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., Andreadis A., Wiederholt W. C., Raskind M., and Schellenberg G. D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
24. Preuss U., Biernat J., Mandelkow E. M., and Mandelkow E. (1997) The 'jaws' model of tau-microtubule interaction examined in CHO cells. J. Cell Sci. 110, 789-800.
25. Spillantini M. G. and Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428-433.
26. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
27. Vallee R. B. (1986) Purification of brain microtubules and microtubule associated protein 1 using taxol. Methods Enzymol. 13, 104-115.
28. van Swieten J. C., Stevens M., Rosso S. M., Rizzu P., Joosse M., de Koning I., Kamphorst W., Ravid R., Spillantini M. G., Niermeijer M. F., and Heutink P. (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46, 617-626.
29. Woodgett J. R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
30. Yen S., Easson C., Nacharaju P., Hutton M., and Yen S. H. (1999) FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett. 461, 91-95.